{"version":"1.0","type":"link","title":"Efficacy and Safety of Neoadjuvant TQB2102 in Locally Advanced or Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: A Randomized, Open-Label, Multicenter, Phase II Trial.","author_name":"Li JJ 외","author_url":"https://prs-insight.online/author/Li%20JJ","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/91777","thumbnail_width":1200,"thumbnail_height":630}